Durham oncology firm lands $45M in new financing
CoImmune, which formerly was known as Argos Therapeutics, has closed on $45 million to help fund its efforts to combat cancer with immunotherapy.
Read MorePosted by WRAL TechWire | Nov 11, 2020
CoImmune, which formerly was known as Argos Therapeutics, has closed on $45 million to help fund its efforts to combat cancer with immunotherapy.
Read MorePosted by WRAL TechWire | Jun 22, 2020
G1 Therapeutics has landed a deal with a China-based company to license an oncology drug. The deal could be worth as much as $46 million.
Read MorePosted by WRAL TechWire | Jun 22, 2020
Chimerix has named Allen Melemed, an MD and a former Elil Lilly executive, as its chief medical officer.
Read MorePosted by WRAL TechWire | Jun 3, 2020
GRAIL, a 5-year-old Menlo Park company whose mission is “to detect cancer early, when it can be cured,” has raised more than $2 billion in venture capital to support its development of a “liquid biopsy” blood test to detect more than 50 types of cancers in people, even before they develop symptoms. Now the company is expanding to North Carolina. Here’s a look at the firm.
Read MorePosted by WRAL TechWire | Oct 12, 2018
Flag Therapeutics Inc., a Raleigh-based oncology and therapy company, has raised $485,000 in equity, according to a securities filing.
Read MorePosted by WRAL TechWire | Jan 11, 2018
A Hong Kong company haspurchased 7.5 million shares of stock for $1.5 million from Argos Therapeutics Inc., a biotechnology company headquartered in Durham.
Read More